Risk stratification in neonates and infants submitted to cardiac surgery with cardiopulmonary bypass: A multimarker approach combining inflammatory mediators, N-terminal pro-B-type natriuretic peptide and troponin I

Cytokine

Volumn 42, Issue 3, 2008, Pages 317-324

  Carmona, Fabio ^a   Manso, Paulo H ^a   Vicente, Walter V A ^a   Castro, Margaret ^a   Carlotti, Ana P C P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cardiopulmonary bypass; Congenital heart defects; Inflammation; Low cardiac output syndrome; Natriuretic peptides

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; APROTININ; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CONTINUOUS INFUSION; CONTROLLED STUDY; FEMALE; FORWARD HEART FAILURE; HEART SURGERY; HUMAN; INFANT; INFANT MORTALITY; MALE; NEWBORN; NEWBORN MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT;

BIOLOGICAL MARKERS; CARDIAC OUTPUT, LOW; CARDIOPULMONARY BYPASS; CYTOKINES; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RISK FACTORS; TROPONIN I;

EID: 44549088484     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.03.005     Document Type: Article

References (35)

1. Seghaye M.C., Engelhardt W., Grabitz R.G., Faymonville M.E., Hornchen H., Messmer B.J., et al. Multiple system organ failure after open heart surgery in infants and children. Thorac Cardiovasc Surg 41 (1993) 49-53
2. Hoffman T.M., Wernovsky G., Atz A.M., Kulik T.J., Nelson D.P., Chang A.C., et al. Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation 107 (2003) 996-1002
3. Brix-Christensen V. The systemic inflammatory response after cardiac surgery with cardiopulmonary bypass in children. Acta Anaesthesiol Scand 45 (2001) 671-679
4. Seghaye M.C. The clinical implications of the systemic inflammatory reaction related to cardiac operations in children. Cardiol Young 13 (2003) 228-239
5. Hovels-Gurich H.H., Vazquez-Jimenez J.F., Silvestri A., Schumacher K., Minkenberg R., Duchateau J., et al. Production of proinflammatory cytokines and myocardial dysfunction after arterial switch operation in neonates with transposition of the great arteries. J Thorac Cardiovasc Surg 124 (2002) 811-820
6. Provenchere S., Berroeta C., Reynaud C., Baron G., Poirier I., Desmonts J.M., et al. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med 34 (2006) 995-1000
7. Mehta N.J., Khan I.A., Gupta V., Jani K., Gowda R.M., and Smith P.R. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 95 (2004) 13-17
8. McCullough P.A., and Sandberg K.R. Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med (2003) S13-S19
9. Chang A.C., Hanley F.L., Wernovsky G., and Wessel D.L. Pediatric cardiac intensive care. 1st ed. (1998), Lippincott, Williams and Wilkins, Baltimore
10. Arnold D.M., Fergusson D.A., Chan A.K., Cook R.J., Fraser G.A., Lim W., et al. Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. Anesth Analg 102 (2006) 731-737
11. Horan M.J. Report of the second task force on blood pressure control in children-1987. Task force on blood pressure control in children. National Heart, Lung, and Blood Institute, Bethesda, MD. Pediatrics 79 (1987) 1-25
12. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
13. American Heart Association. PALS-Pediatric Advanced Life Support-Provider Manual. Portuguese ed. Buenos Aires: Waverly Hispanica S.A.; 2002.
14. Wernovsky G., Wypij D., Jonas R.A., Mayer Jr. J.E., Hanley F.L., Hickey P.R., et al. Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation 92 (1995) 2226-2235
15. Schwartz G.J., Haycock G.B., and Spitzer A. Plasma creatinine and urea concentration in children: normal values for age and sex. J Pediatr 88 (1976) 828-830
16. Leteurtre S., Martinot A., Duhamel A., Proulx F., Grandbastien B., Cotting J., et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet 362 (2003) 192-197
17. Jenkins K.J. Risk adjustment for congenital heart surgery: the RACHS-1 method. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 7 (2004) 180-184
18. Pollack M.M., Ruttimann U.E., and Getson P.R. Pediatric risk of mortality (PRISM) score. Crit Care Med 16 (1988) 1110-1116
19. Concato J., Feinstein A.R., and Holford T.R. The risk of determining risk with multivariable models. Ann Intern Med 118 (1993) 201-210
20. Hasegawa T., Yamaguchi M., Yoshimura N., and Okita Y. The dependence of myocardial damage on age and ischemic time in pediatric cardiac surgery. J Thorac Cardiovasc Surg 129 (2005) 192-198
21. Gessler P., Knirsch W., Schmitt B., Rousson V., and von Eckardstein A. Prognostic value of plasma N-terminal pro-brain natriuretic peptide in children with congenital heart defects and open-heart surgery. J Pediatr 148 (2006) 372-376
22. Tarnok A., Hambsch J., Emmrich F., Sack U., van Son J., Bellinghausen W., et al. Complement activation, cytokines, and adhesion molecules in children undergoing cardiac surgery with or without cardiopulmonary bypass. Pediatr Cardiol 20 (1999) 113-125
23. Holmes IV J.H., Connolly N.C., Paull D.L., Hill M.E., Guyton S.W., Ziegler S.F., et al. Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes. Inflamm Res 51 (2002) 579-586
24. Hoshikawa-Fujimura A.Y., Auler Junior J.O., Da Rocha T.R., Brandizzi L.I., Pascual J.M., Chamone D.A., et al. PAF-acether, superoxide anion and beta-glucuronidase as parameters of polymorphonuclear cell activation associated with cardiac surgery and cardiopulmonary bypass. Braz J Med Biol Res 22 (1989) 1077-1082
25. Zehr K.J., Poston R.S., Lee P.C., Uthoff K., Kumar P., Cho P.W., et al. Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass. Ann Thorac Surg 59 (1995) 328-335
26. Sawa Y., Schaper J., Roth M., Nagasawa K., Ballagi G., Bleese N., et al. Platelet-activating factor plays an important role in reperfusion injury in myocardium. Efficacy of platelet-activating factor receptor antagonist (CV-3988) as compared with leukocyte-depleted reperfusion. J Thorac Cardiovasc Surg 108 (1994) 953-959
27. Zimmerman G.A., McIntyre T.M., Prescott S.M., and Stafforini D.M. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 30 (2002) S294-S301
28. Kasperska-Zajac A., and Rogala B. Platelet activation during allergic inflammation. Inflammation 30 (2007) 161-166
29. Mildh L.H., Pettila V., Sairanen H.I., and Rautiainen P.H. Cardiac troponin T levels for risk stratification in pediatric open heart surgery. Ann Thorac Surg 82 (2006) 1643-1648
30. Marcil M., Ascah A., Matas J., Belanger S., Deschepper C.F., and Burelle Y. Compensated volume overload increases the vulnerability of heart mitochondria without affecting their functions in the absence of stress. J Mol Cell Cardiol 41 (2006) 998-1009
31. Myrianthefs PM, Lazaris N, Venetsanou K, Smigadis N, Karabatsos E, Anastasiou-Nana MI, et al. Immune status evaluation of patients with chronic heart failure. Cytokine 2007; Epub ahead of print.
32. Gwechenberger M., Hulsmann M., Berger R., Graf S., Springer C., Stanek B., et al. Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure. J Heart Lung Transplant 23 (2004) 839-844
33. Elenkov I.J. Glucocorticoids and the Th1/Th2 balance. Ann NY Acad Sci 1024 (2004) 138-146
34. Brown J.M. Use of echocardiography for hemodynamic monitoring. Crit Care Med 30 (2002) 1361-1364
35. Mir T.S., Laux R., Hellwege H.H., Liedke B., Heinze C., von Buelow H., et al. Plasma concentrations of aminoterminal pro atrial natriuretic peptide and aminoterminal pro brain natriuretic peptide in healthy neonates: marked and rapid increase after birth. Pediatrics 112 (2003) 896-899